Serious side effects are very rare but can include pancreatitis or thyroid tumors
Recently, the GIP/GLP-1R co-agonist tirzepatide has gone through several randomized controlled trials and was approved by the FDA for T2DM and obesity in 2022 and 2023, respectively
The 1998 report found ipamorelin released GH without elevating ACTH or cortisol beyond what GHRH stimulation produced, and later work describes no significant elevation of prolactin, FSH, LH or TSH even at doses reported as more than 200-fold above the GH-releasing ED50
FDA Approves weight management drug for patients aged 12 and older (2020)
Cartman, Stan, Kyle, Kenny, and Butters are all trying to get Cartman a prescription for Ozempic but run into the various obstacles and red tape of the American healthcare system